Regulatory Guidelines
6 min read
ICH M7(R1) Nitrosamine Risk Assessment: Practical Strategies for Pharmaceutical Manufacturers
Comprehensive overview of calculating Acceptable Intake (AI) limits for NDSRIs, mutagenicity testing, and CPCA (Carcinogenic Potency Categorization Approach) rules.
By Karpschem Technical Team
ยท
March 15, 2026
Read Article โ